• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环 miRNA 作为肺动脉高压的潜在标志物。

Circulating miRNAs as potential marker for pulmonary hypertension.

机构信息

Division of Molecular Cardiology, Department of Medicine, College of Medicine, Texas A&M Health Science Center, Scott & White, Central Texas Veterans Health Care System, Temple, Texas, United States of America.

出版信息

PLoS One. 2013 May 23;8(5):e64396. doi: 10.1371/journal.pone.0064396. Print 2013.

DOI:10.1371/journal.pone.0064396
PMID:23717609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3662705/
Abstract

MircoRNAs (miRNAs) are small non-coding RNAs that govern the gene expression and, play significant role in the pathogenesis of heart failure. The detection of miRNAs in circulation of pulmonary hypertensive (PH) human subjects remains elusive. In the current study, we determined the pattern of miRNAs of mild-to-severe human PH subjects and, compared them with the control subjects by miRNA array. Blood was obtained using fluoroscopic and waveform guided catheterization from the distal (pulmonary artery) port of the catheter. A total 40 human subjects were included in the study and, the degree of PH was determined by mean pulmonary arterial pressure. Among several miRNAs in the array, we validated 14 miRNAs and, the data were consistent with the array profile. We identified several novel downregulated miRNAs (miR-451, miR-1246) and upregulated miRNAs (miR-23b, miR-130a and miR-191) in the circulation of PH subjects. Our study showed novel set of miRNAs which are dysregulated in PH and, are directly proportional to the degree of PH. These miRNAs may be considered as potential biomarker for early detection of PH.

摘要

微小 RNA(miRNAs)是一种小型非编码 RNA,能够调控基因表达,在心力衰竭的发病机制中发挥重要作用。在肺动脉高压(PH)患者的循环中检测到 miRNAs 仍然难以实现。在本研究中,我们通过 miRNA 阵列确定了轻度至重度 PH 患者的 miRNA 模式,并将其与对照组进行了比较。通过荧光透视和波形引导导管从导管的远端(肺动脉)端口采集血液。共有 40 名受试者纳入本研究,通过平均肺动脉压确定 PH 的程度。在阵列中的几种 miRNAs 中,我们验证了 14 种 miRNAs,数据与阵列图谱一致。我们在 PH 患者的循环中发现了几种新的下调 miRNA(miR-451、miR-1246)和上调 miRNA(miR-23b、miR-130a 和 miR-191)。我们的研究显示了一组在 PH 中失调的新型 miRNAs,并且与 PH 的程度呈正相关。这些 miRNA 可以被认为是早期检测 PH 的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d97/3662705/d904057a3394/pone.0064396.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d97/3662705/fede1a5b0756/pone.0064396.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d97/3662705/84e344e16af0/pone.0064396.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d97/3662705/6c9cb6d4c3db/pone.0064396.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d97/3662705/de097e5c189f/pone.0064396.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d97/3662705/d904057a3394/pone.0064396.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d97/3662705/fede1a5b0756/pone.0064396.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d97/3662705/84e344e16af0/pone.0064396.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d97/3662705/6c9cb6d4c3db/pone.0064396.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d97/3662705/de097e5c189f/pone.0064396.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d97/3662705/d904057a3394/pone.0064396.g005.jpg

相似文献

1
Circulating miRNAs as potential marker for pulmonary hypertension.循环 miRNA 作为肺动脉高压的潜在标志物。
PLoS One. 2013 May 23;8(5):e64396. doi: 10.1371/journal.pone.0064396. Print 2013.
2
Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease.循环微RNA作为先天性心脏病所致肺动脉高压的新型生物标志物
Pediatr Cardiol. 2017 Jan;38(1):86-94. doi: 10.1007/s00246-016-1487-3. Epub 2016 Nov 11.
3
Detection of Differentially Expressed MicroRNAs in Rheumatic Heart Disease: miR-1183 and miR-1299 as Potential Diagnostic Biomarkers.风湿性心脏病中差异表达微小RNA的检测:miR-1183和miR-1299作为潜在的诊断生物标志物
Biomed Res Int. 2015;2015:524519. doi: 10.1155/2015/524519. Epub 2015 Oct 11.
4
MicroRNA profiling identifies miR-7-5p and miR-26b-5p as differentially expressed in hypertensive patients with left ventricular hypertrophy.微小RNA分析鉴定出miR-7-5p和miR-26b-5p在伴有左心室肥厚的高血压患者中存在差异表达。
Braz J Med Biol Res. 2017 Oct 19;50(12):e6211. doi: 10.1590/1414-431X20176211.
5
Plasma miR-21: a potential diagnostic marker of colorectal cancer.血浆 miR-21:结直肠癌的潜在诊断标志物。
Ann Surg. 2012 Sep;256(3):544-51. doi: 10.1097/SLA.0b013e318265bd6f.
6
Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p.鉴定用于检测肺癌的血清微小RNA表达特征,涉及miR-23b、miR-221、miR-148b和miR-423-3p。
Lung Cancer. 2017 Dec;114:6-11. doi: 10.1016/j.lungcan.2017.10.002. Epub 2017 Oct 5.
7
Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease.循环 miR-155-5p 作为腰椎退行性椎间盘疾病的新型生物标志物。
Spine (Phila Pa 1976). 2020 May 1;45(9):E499-E507. doi: 10.1097/BRS.0000000000003322.
8
Circulating microRNA expression as predictor of preeclampsia and its severity.循环微小RNA表达作为子痫前期及其严重程度的预测指标。
Gene. 2017 Sep 5;627:543-548. doi: 10.1016/j.gene.2017.07.010. Epub 2017 Jul 8.
9
Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease.血清微小RNA作为慢性阻塞性肺疾病潜在生物标志物的分析
Exp Lung Res. 2012 Aug;38(6):286-94. doi: 10.3109/01902148.2012.689088. Epub 2012 Jun 11.
10
Discordant Regulation of microRNA Between Multiple Experimental Models and Human Pulmonary Hypertension.多种实验模型与人类肺动脉高压之间微小RNA的不一致调控
Chest. 2015 Aug;148(2):481-490. doi: 10.1378/chest.14-2169.

引用本文的文献

1
Ambrisentan Retains Its Pro-Autophagic Activity on Human Pulmonary Artery Endothelial Cells Exposed to Hypoxia in an In Vitro Model Mimicking Diabetes.在模拟糖尿病的体外模型中,安立生坦对暴露于缺氧环境的人肺动脉内皮细胞保持其促自噬活性。
J Cell Mol Med. 2025 Apr;29(7):e70528. doi: 10.1111/jcmm.70528.
2
Multi-omics architecture of childhood obesity and metabolic dysfunction uncovers biological pathways and prenatal determinants.儿童肥胖和代谢功能障碍的多组学结构揭示了生物学途径和产前决定因素。
Nat Commun. 2025 Jan 14;16(1):654. doi: 10.1038/s41467-025-56013-7.
3
Extracellular Vesicles Induce Nuclear Factor-κB Activation and Interleukin-8 Synthesis through miRNA-191-5p Contributing to Inflammatory Processes: Potential Implications in the Pathogenesis of Chronic Obstructive Pulmonary Disease.

本文引用的文献

1
A new level of complexity: the role of microRNAs in cardiovascular development.新的复杂性层次:microRNAs 在心血管发育中的作用。
Circ Res. 2012 Mar 30;110(7):1000-13. doi: 10.1161/CIRCRESAHA.111.247742.
2
Lipid-based carriers of microRNAs and intercellular communication.miRNAs 的脂基载体与细胞间通讯。
Curr Opin Lipidol. 2012 Apr;23(2):91-7. doi: 10.1097/MOL.0b013e328350a425.
3
Missense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertension.BMPR1B(ALK6)基因突变与儿童特发性肺动脉高压。
细胞外囊泡通过 miRNA-191-5p 诱导核因子-κB 激活和白细胞介素-8 合成,从而促进炎症过程:在慢性阻塞性肺疾病发病机制中的潜在意义。
Biomolecules. 2024 Aug 19;14(8):1030. doi: 10.3390/biom14081030.
4
Fibroblasts in Pulmonary Hypertension: Roles and Molecular Mechanisms.肺高血压中的成纤维细胞:作用和分子机制。
Cells. 2024 May 25;13(11):914. doi: 10.3390/cells13110914.
5
Recent progress in the roles of microRNAs in pulmonary arterial hypertension associated with congenital heart disease.微小 RNA 在先天性心脏病相关肺动脉高压中的作用的最新进展。
Narra J. 2024 Apr;4(1):e579. doi: 10.52225/narra.v4i1.579. Epub 2024 Feb 28.
6
Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update.肺动脉高压的循环生物标志物:更新。
Biomolecules. 2024 May 3;14(5):552. doi: 10.3390/biom14050552.
7
Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension.循环 microRNA-21 和 microRNA-143 的减少与肺动脉高压有关。
Turk J Med Sci. 2023 Feb;53(1):130-141. doi: 10.55730/1300-0144.5566. Epub 2023 Feb 22.
8
Emerging role of exosomes in vascular diseases.外泌体在血管疾病中的新兴作用。
Front Cardiovasc Med. 2023 Mar 2;10:1090909. doi: 10.3389/fcvm.2023.1090909. eCollection 2023.
9
Altered microRNA Transcriptome in Cultured Human Airway Cells upon Infection with SARS-CoV-2.感染 SARS-CoV-2 后培养的人呼吸道细胞中微小 RNA 转录组的改变。
Viruses. 2023 Feb 10;15(2):496. doi: 10.3390/v15020496.
10
Biomarkers in Pulmonary Arterial Hypertension.肺动脉高压中的生物标志物
Diagnostics (Basel). 2022 Dec 3;12(12):3033. doi: 10.3390/diagnostics12123033.
Circ J. 2012;76(6):1501-8. doi: 10.1253/circj.cj-11-1281. Epub 2012 Feb 25.
4
MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach.miRNA-21 通过整合致病信号来控制肺动脉高压:网络生物信息学方法的研究结果。
Circulation. 2012 Mar 27;125(12):1520-32. doi: 10.1161/CIRCULATIONAHA.111.060269. Epub 2012 Feb 27.
5
Secreted microRNAs: a new form of intercellular communication.分泌 microRNAs:一种新的细胞间通讯形式。
Trends Cell Biol. 2012 Mar;22(3):125-32. doi: 10.1016/j.tcb.2011.12.001. Epub 2012 Jan 17.
6
Cardiac-specific genetic inhibition of nuclear factor-κB prevents right ventricular hypertrophy induced by monocrotaline.心脏特异性核因子-κB 基因抑制可预防野百合碱诱导的右心室肥厚。
Am J Physiol Heart Circ Physiol. 2012 Apr 15;302(8):H1655-66. doi: 10.1152/ajpheart.00756.2011. Epub 2012 Jan 13.
7
miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.miR-21 调节慢性缺氧诱导的肺血管重构。
Am J Physiol Lung Cell Mol Physiol. 2012 Mar 15;302(6):L521-9. doi: 10.1152/ajplung.00316.2011. Epub 2012 Jan 6.
8
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.miR-29 家族:基因组学、细胞生物学及与肾和心血管损伤的相关性。
Physiol Genomics. 2012 Feb 27;44(4):237-44. doi: 10.1152/physiolgenomics.00141.2011. Epub 2012 Jan 3.
9
Overview of current therapeutic approaches for pulmonary hypertension.肺动脉高压的当前治疗方法概述。
Pulm Circ. 2011 Apr-Jun;1(2):138-59. doi: 10.4103/2045-8932.83444.
10
Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?循环 microRNAs:心血管疾病的生物标志物还是介质?
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2383-90. doi: 10.1161/ATVBAHA.111.226696.